Barclays PLC Cortexyme, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Cortexyme, Inc. stock. As of the latest transaction made, Barclays PLC holds 100 shares of CRTX stock, worth $129. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 100 -0.0%

Holding current value

$129

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	N/A	-100 Reduced 50.0%	100 $0
Q3 2023 Nov 07, 2023	BUY	N/A	100 Added 100.0%	200 $0
Q1 2023 May 04, 2023	BUY	N/A	100 New	100 $0
Q2 2022 Aug 12, 2022	SELL	$2.22 - $6.7 $7,368 - $22,237	-3,319 Reduced 76.85%	1,000 $2,000
Q1 2022 May 16, 2022	SELL	$4.18 - $13.39 $90,827 - $290,951	-21,729 Reduced 83.42%	4,319 $26,000
Q4 2021 Feb 14, 2022	BUY	$11.35 - $97.17 $201,973 - $1.73 Million	17,795 Added 215.62%	26,048 $329,000
Q3 2021 Nov 09, 2021	BUY	$52.0 - $120.21 $288,652 - $667,285	5,551 Added 205.44%	8,253 $756,000
Q2 2021 Aug 13, 2021	SELL	$31.88 - $58.66 $338,661 - $623,145	-10,623 Reduced 79.72%	2,702 $143,000
Q1 2021 May 13, 2021	BUY	$28.6 - $49.21 $227,741 - $391,859	7,963 Added 148.51%	13,325 $480,000
Q4 2020 Feb 11, 2021	SELL	$27.78 - $56.93 $51,004 - $104,523	-1,836 Reduced 25.51%	5,362 $149,000
Q3 2020 Nov 12, 2020	SELL	$39.85 - $57.3 $57,862 - $83,199	-1,452 Reduced 16.79%	7,198 $360,000
Q2 2020 Aug 12, 2020	BUY	$34.93 - $57.75 $168,257 - $278,181	4,817 Added 125.67%	8,650 $400,000
Q1 2020 May 13, 2020	SELL	$29.01 - $72.51 $240,202 - $600,382	-8,280 Reduced 68.36%	3,833 $175,000
Q4 2019 Feb 10, 2020	BUY	$20.77 - $68.91 $218,895 - $726,242	10,539 Added 669.57%	12,113 $680,000
Q3 2019 Nov 14, 2019	SELL	$19.85 - $45.28 $87,022 - $198,507	-4,384 Reduced 73.58%	1,574 $39,000
Q2 2019 Aug 14, 2019	BUY	$23.86 - $42.51 $142,157 - $253,274	5,958 New	5,958 $253,000

Others Institutions Holding CRTX

# of Institutions

Shares Held

5.21M

Call Options Held

90.8K

Put Options Held

View Full List

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account